ConsenSys and Intel use blockchain to fight Covid-19
- August 23, 2021
- Steve Rogerson
Healthcare software provider ConsenSys Health is using blockchain-based data security fuelled by Intel technology to help combat Covid-19.
The New York company is conducting research into making clinical trial recruitment more efficient and equitable.
On the heels of the World Health Organisation’s first global report on the use of artificial intelligence for healthcare and medicine, ConsenSys Health is seizing opportunities to apply technology that helps protect patient privacy while increasing efficiency with the goal of combating the coronavirus.
“Long-standing industry challenges have only intensified throughout the Covid-19 pandemic,” said Sean Manion, chief scientific officer for ConsenSys Health. “This is especially true for marginalised communities who consistently battle inequities in access to clinical trials. With the help of Intel’s Pandemic Response Technology Initiative (PRTI) and Intel technology, we are able to better work towards making healthcare more equitable for all.”
Clinical trial recruitment is expensive, inefficient and time-consuming. As Covid-19 therapeutics move through fast-tracked research pipelines and into clinical trials, it is critical to recruit patients – including those from more vulnerable populations who consistently battle inequities in access to care – into those trials while protecting patient privacy.
ConsenSys and a large pharmaceutical company researched a privacy-preserving blockchain-orchestrated federated computing approach to clinical trial matching. Processing electronic health record data was considerably faster with hardware-enhanced security through ConsenSys Health’s elevated compute platform optimised for Intel SGX software guard extensions on the third-generation Xeon scalable platform, compared with previous systems.
The benefits of this privacy-preserving approach can be applied across the global pharmaceutical industry to improve patient matching for clinical trials and accelerate treatment discoveries.
The Covid-19 pandemic brought to light data security challenges and inefficiencies that exist within the healthcare industry. Through grants from PRTI, companies such as ConsenSys Health can gain accelerated access to Intel security and built-in AI technologies required to fuel novel research and scientific discoveries.
As workloads expand from the cloud to the edge, threat models are evolving and it’s more important than ever to secure sensitive data. Rooted in silicon, Intel hardware-based security creates a trusted foundation to help protect data and support multiparty collaboration in regulated industries, such as healthcare, while helping maintain data privacy and compliance.